WHITEHAWK THERAPEUTICS, INC. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-03-28
- WHITEHAWK THERAPEUTICS, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $0.00.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |